Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa

NCT05285917 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Anemia in Children
Sickle Cell Disease

Interventions

DRUG: Hydroxyurea

Sponsor

Brown University

Collaborators

[object Object]
[object Object]